- Changing foreign relations priorities in US
- History of the US BioSecure Act, its future, and potential impact on the Pharmaceutical Industry
- US pharma industry reliance on foreign CROs and CDMOs to advance research
- Risk assessment for companies with ongoing drug development activities with a foreign CRO/CDMO
